Efficacy of Psychological Treatments for Patients With Schizophrenia and Relevant Negative Symptoms: A Meta-Analysis
- PMID: 36398145
- PMCID: PMC9645476
- DOI: 10.32872/cpe.v2i3.2899
Efficacy of Psychological Treatments for Patients With Schizophrenia and Relevant Negative Symptoms: A Meta-Analysis
Abstract
Background: Recent meta-analyses on the efficacy of psychological treatments for the negative symptoms of schizophrenia included mostly trials that had not specifically targeted negative symptoms. To gauge the efficacy of such treatments in the target patient population - namely people with schizophrenia who experience negative symptoms - we conducted a meta-analysis of controlled trials that had established an inclusion criterion for relevant negative symptom severity.
Method: We conducted a systematic literature search and calculated random-effects meta-analyses for controlled post-treatment effects and for pre-post changes within treatment arms. Separate analyses were conducted for different therapeutic approaches. Our primary outcome was reduction in negative symptoms; secondary outcomes were amotivation, reduced expression, and functioning.
Results: Twelve studies matched our inclusion criteria, testing Cognitive Behavioral Therapy (CBT) vs. treatment-as-usual (k = 6), Cognitive Remediation (CR) vs. treatment-as-usual (k = 2), CBT vs. CR (k = 2), and Body-oriented Psychotherapy (BPT) vs. supportive group counseling and vs. Pilates (k = 1 each). Accordingly, meta-analyses were performed for CBT vs. treatment-as-usual, CR vs. treatment-as-usual, and CBT vs. CR. CBT and CR both outperformed treatment-as-usual in reducing negative symptoms (CBT: Hedges' g = -0.46; CR: g = -0.59). There was no difference between CBT and CR (g = 0.12). Significant pre-post changes were found for CBT, CR, and to a lesser extent for treatment-as-usual, but not for BPT.
Conclusion: Although effects for some approaches are promising, more high-quality trials testing psychological treatments for negative symptoms in their target population are needed to place treatment recommendations on a sufficiently firm foundation.
Keywords: meta-analysis; negative symptoms; nonpharmacological treatment; psychotherapy; schizophrenia and psychosis.
Conflict of interest statement
TML is first author of German treatment manuals for CBTp. All other authors declare that they have no conflict of interest.
Figures
Similar articles
-
Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.Ont Health Technol Assess Ser. 2018 Oct 24;18(5):1-141. eCollection 2018. Ont Health Technol Assess Ser. 2018. PMID: 30443277 Free PMC article. Review.
-
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression.Psychol Med. 2015 Feb;45(3):453-65. doi: 10.1017/S0033291714001147. Epub 2014 May 22. Psychol Med. 2015. PMID: 24993642 Review.
-
Bouldering psychotherapy is not inferior to cognitive behavioural therapy in the group treatment of depression: A randomized controlled trial.Br J Clin Psychol. 2022 Jun;61(2):465-493. doi: 10.1111/bjc.12347. Epub 2021 Nov 17. Br J Clin Psychol. 2022. PMID: 34791669 Clinical Trial.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Psychosocial interventions for conversion and dissociative disorders in adults.Cochrane Database Syst Rev. 2020 Jul 17;7(7):CD005331. doi: 10.1002/14651858.CD005331.pub3. Cochrane Database Syst Rev. 2020. PMID: 32681745 Free PMC article.
Cited by
-
Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?Schizophr Res Cogn. 2024 May 12;37:100317. doi: 10.1016/j.scog.2024.100317. eCollection 2024 Sep. Schizophr Res Cogn. 2024. PMID: 38745931 Free PMC article.
-
Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses.Br J Psychiatry. 2023 Jul;223(1):321-331. doi: 10.1192/bjp.2023.21. Br J Psychiatry. 2023. PMID: 36919340 Free PMC article.
-
Prescription Digital Therapeutics: An Emerging Treatment Option for Negative Symptoms in Schizophrenia.Biol Psychiatry. 2024 Oct 15;96(8):659-665. doi: 10.1016/j.biopsych.2024.06.026. Epub 2024 Jul 1. Biol Psychiatry. 2024. PMID: 38960019 Review.
-
Efficacy of behavioural activation in the treatment of negative symptoms in people with schizophrenia spectrum disorders: A systematic review.Int J Nurs Stud Adv. 2023 May 15;5:100132. doi: 10.1016/j.ijnsa.2023.100132. eCollection 2023 Dec. Int J Nurs Stud Adv. 2023. PMID: 38746587 Free PMC article. Review.
-
Australian trial of behavioural activation for people with schizophrenia experiencing negative symptoms: a feasibility randomised controlled trial protocol.BMJ Open. 2024 May 6;14(5):e080245. doi: 10.1136/bmjopen-2023-080245. BMJ Open. 2024. PMID: 38719282 Free PMC article.
References
-
- Riehle M., Böhl M. C., Pillny M., Lincoln T. M. (2020). Supplementary materials to "Efficacy of psychological treatments for patients with schizophrenia and relevant negative symptoms: A meta-analysis" [Formulae, additional results, and discussion]. PsychOpen. 10.23668/psycharchives.3482 - DOI - PMC - PubMed
-
- Alphs L. D., Summerfelt A., Lann H., Muller R. J. (1989). The negative symptom assessment: A new instrument to assess negative symptoms of schizophrenia. Psychopharmacology Bulletin, 25(2), 159–163. - PubMed
-
- Bailer J., Takats I., Westermeier C. (2001). Die Wirksamkeit individualisierter Kognitiver Verhaltenstherapie bei schizophrener Negativsymptomatik und sozialer Behinderung. Zeitschrift für Klinische Psychologie und Psychotherapie, 30(4), 268–278. 10.1026/0084-5345.30.4.268 - DOI
Publication types
LinkOut - more resources
Full Text Sources